Atrium Therapeutics, Inc.RNANASDAQ
Loading
R&D Expenses Over TimeStable
Studio

Research and development spending

Latest
$53.76M
Near historical average
Average
$53.76M
Historical baseline
PeriodValueYoY Change
2025$53.76M-